Hinog, Kiara .
HRN: 22-39-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2023
MUPIROCIN 2%, 15G (TUBE)
02/14/2023
02/21/2023
TOPICAL
TID
TID
Infected Umbilical Stump
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes